Search Results - "SINGH, Rajeeva"
-
1
Tumor Delivery and In Vivo Processing of Disulfide-Linked and Thioether-Linked Antibody−Maytansinoid Conjugates
Published in Bioconjugate chemistry (20-01-2010)“…Antibody−drug conjugates (ADCs) are designed to eradicate cancer cells that express the target antigen on their cell surface. A key component of an ADC is the…”
Get full text
Journal Article -
2
Synthesis and Evaluation of Hydrophilic Linkers for Antibody–Maytansinoid Conjugates
Published in Journal of medicinal chemistry (26-05-2011)“…The synthesis and biological evaluation of hydrophilic heterobifunctional cross-linkers for conjugation of antibodies with highly cytotoxic agents are…”
Get full text
Journal Article -
3
Disulfide-Linked Antibody−Maytansinoid Conjugates: Optimization of In Vivo Activity by Varying the Steric Hindrance at Carbon Atoms Adjacent to the Disulfide Linkage
Published in Bioconjugate chemistry (20-04-2011)“…In this report, we describe the synthesis of a panel of disulfide-linked huC242 (anti-CanAg) antibody maytansinoid conjugates (AMCs), which have varying levels…”
Get full text
Journal Article -
4
A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody-Drug Conjugates (ADCs)
Published in Molecular cancer therapeutics (01-03-2018)“…Tumor-selective delivery of cytotoxic agents in the form of antibody-drug conjugates (ADCs) is now a clinically validated approach for cancer treatment. In an…”
Get full text
Journal Article -
5
Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance
Published in Cancer research (Chicago, Ill.) (15-03-2010)“…Conjugation of cytotoxic compounds to antibodies that bind to cancer-specific antigens makes these drugs selective in killing cancer cells. However, many of…”
Get full text
Journal Article -
6
198 Spectrum of symptoms in covid-19 paediatric patients across four district general hospitals in Yorkshire
Published in BMJ paediatrics open (01-04-2021)“…BackgroundDespite increasing reports and studies about COVID-19 in children over the last nine months, there is still much to be discovered about the true…”
Get full text
Journal Article -
7
Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor : Implications for anti-insulin-like growth factor therapy in breast cancer
Published in Cancer research (Chicago, Ill.) (15-02-2006)“…Insulin-like growth factor-I (IGF-I), IGF-II, and insulin have all been implicated in regulating several aspects of the malignant phenotype via the type I IGF…”
Get full text
Journal Article -
8
1646 Spectrum of symptoms in COVID-19 paediatric patients across four district general hospitals in yorkshire
Published in Archives of disease in childhood (01-10-2021)“…BackgroundDespite increasing reports and studies about COVID-19 in children over the last nine months, there is still much to be discovered about the true…”
Get full text
Journal Article -
9
Insight Into the Degradation Pathways of an AAV9
Published in Journal of pharmaceutical sciences (01-09-2024)“…The use of recombinant adeno-associated virus (AAV) vectors is a popular choice for in vivo gene therapy, with hundreds of ongoing clinical trials targeting…”
Get more information
Journal Article -
10
IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors
Published in Molecular cancer therapeutics (01-07-2015)“…A majority of ovarian and non-small cell lung adenocarcinoma cancers overexpress folate receptor α (FRα). Here, we report the development of an anti-FRα…”
Get full text
Journal Article -
11
Sensitive ELISA Method for the Measurement of Catabolites of Antibody–Drug Conjugates (ADCs) in Target Cancer Cells
Published in Molecular pharmaceutics (01-06-2015)“…A new, sensitive ELISA method has been developed which measures catabolites in cells and media upon processing of antibody–drug conjugates (ADCs) by target…”
Get full text
Journal Article -
12
Catalysis of Reduction of Disulfide by Selenol
Published in Analytical biochemistry (20-11-1995)“…The reduction of a disulfide to thiols, using sodium borohydride or dithiothreitol as reductant, is catalyzed by selenol. The rates of reduction of oxidized…”
Get full text
Journal Article -
13
Formation of N-Substituted 2-Iminothiolanes When Amino Groups in Proteins and Peptides Are Modified by 2-Iminothiolane
Published in Analytical biochemistry (05-04-1996)“…The reagent 2-iminothiolane (2-IT) is used to introduce thiol groups into proteins and peptides by reactions of their amino groups. In this study, we report…”
Get full text
Journal Article -
14
Design of Antibody−Maytansinoid Conjugates Allows for Efficient Detoxification via Liver Metabolism
Published in Bioconjugate chemistry (20-04-2011)“…Antibody−maytansinoid conjugates (AMCs) are targeted chemotherapeutic agents consisting of a potent microtubule-depolymerizing maytansinoid (DM1 or DM4)…”
Get full text
Journal Article -
15
Selenols catalyze the interchange reactions of dithiols and disulfides in water
Published in Journal of organic chemistry (01-11-1991)Get full text
Journal Article -
16
OC13 Sydenham’s chorea – A rare condition?
Published in Archives of disease in childhood (01-06-2019)“…Sydenham’s chorea (SC) is considered a ‘rare disease’ in Western Europe and not much is known about its incidence in the UK 1.SC is a major criteria for…”
Get full text
Journal Article -
17
-
18
Abstract 230: Antibody-drug conjugates (ADCs) with indolinobenzodiazepine dimer (IGN) payloads: DNA-binding mechanism of IGN catabolites in target cancer cells
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract A DNA-interacting indolinobenzodiazepine dimer (IGN) payload was designed with a single reactive imine group towards the goal of eliminating DNA…”
Get full text
Journal Article -
19
A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating Activity
Published in Molecular cancer therapeutics (01-08-2016)“…The promise of tumor-selective delivery of cytotoxic agents in the form of antibody-drug conjugates (ADC) has now been realized, evidenced by the approval of…”
Get full text
Journal Article -
20
Abstract B130: Correlation of in vitro cytotoxicity and catabolism of antibody-drug conjugates (ADCs) in target cancer cells
Published in Molecular cancer therapeutics (01-12-2015)“…Abstract A sensitive and convenient ELISA method has been developed to quantify catabolites generated upon treatment of target cancer cells with an…”
Get full text
Journal Article